New in-depth report now available from the International Publication Planning Associations 2010 Midwest Meeting: tackling the authorship debate in publication planning
12 May 2010, NetworkPharma Ltd, Oxford, UK have published another in their KeywordPharma series of Conference Insights Reports intended for individuals working in and around the global pharmaceutical industry.
The new in-depth report from the International Publication Planning Associations 2010 Midwest Meeting: tackling the authorship debate in publication planning is now available to purchase, written by Clare Nolan.
The global landscape for medical publications planning is changing dramatically. With guidelines and regulations acknowledged as the most prominent tools for implementing sound scientific publication practice, the regulatory environment has been tightened in recent years while further recommendations are on the horizon.
Critics allege that nowadays it is difficult to separate the pharma industry’s advertising and marketing from the science. Confidence in the industry is low. So how can progress be made? Developing a global one-size-fits-all policy is compromised by significant differences in global and local requirements. Without a uniform approach, self-advocacy is highlighted as a key route to cleaning up the industry’s act and re-establishing confidence. Transparency, integrity, accountability and disclosure are heralded as the best means of achieving success. Introducing more guidelines, however, is not considered to be the answer. Instead, collaborative working between organisations who share the objective - to ensure that publications policies are completely explicit - is seen as the way forward.
This Conference Insights review provides an in-depth review of The International Publication Planning Association’s 2010 Midwest Meeting: tackling the authorship debate in publication planning. It details the most salient issues driving publication planning in a much-scrutinised and ever changing environment. In particular it focuses on:
current and imminent regulations
author selection
the battle to distinguish between scientific exchange, education and promotion
developing an adequate audit trail
defining the role of the agency
the importance of disclosure
developing and sharing a comprehensive publications policy.
It looks at the latest legal and compliance issues, providing perspectives from editors, authors, pharmaceutical companies, agencies and regulators seeking to establish how standards can be improved.
All KeywordPharma publications can be purchased from ThePharmYard at www.ThePharmYard.com
NOTES
About the author
Clare Nolan is a co-founder of The Recognition Academy, a training company that helps physicians and the pharmaceutical industry work together. She has over 20 years’ experience in drug development and brand commercialisation within academia and the pharmaceutical industry.
After obtaining a degree in pharmacy and a PhD in prostate cancer drug development from Cardiff School of Pharmacy and Medicine, UK (sponsored by the Cancer Research Campaign), Clare worked at Eli Lilly & Company and Lilly Research in neuroscience product development, clinical trial design and sales. As a Regulatory Manager at GSK, she led European license submissions for new cardiovascular products and in-licensing agreements in respiratory products. At Strategic Consultants International, she led clinical development advisory boards and continuing medical education programmes throughout Europe, the USA and Asia. At AstraZeneca, she was responsible for global publications and communications from early pipeline and prelaunch to postlaunch for products in oncology, urology, immunology and cardiovascular and infectious diseases. On behalf of academia and industry, she has established global opinion leader networks, profile management tools and company-wide opinion leader relationship management systems. Clare has trained global cross-functional teams on publications issues and challenges, internal policies and external guidelines. Most recently, as Director of Professional Development with Lionsden Communications, she has trained opinion leaders and emerging leaders in spoken communication, to their peers. She is a member of ISMPP.
As a Director at The Recognition Academy, Clare trains physicians on how to partner with the pharma industry so they can gain recognition for their contribution to medicine with enhanced reputation and credibility. The Academy also trains industry professionals to partner effectively and ethically with physicians, enabling them to advance patient care whilst upholding their reputation.
Written by pharmaceutical industry specialists, KeywordPharma publications are designed to be authoritative, relevant, succinct and helpful to pharmaceutical industry executives in their day-to-day work and in their longer term career development. Available to purchase individually as e-documents, they build into a specialist knowledge library for everyone working in and around the global pharmaceutical industry.
Developed and managed by NetworkPharma Ltd, ThePharmYard provides instant access to a unique database of specialist information which is particularly relevant to individuals working within the medical and pharmaceutical industries around the world. Titles from a diverse range of independent publishers are available to purchase in electronic document format for immediate access.
NetworkPharma Ltd is an independent, specialist company founded by Peter Llewellyn, to focus on novel approaches to disseminating information within the global medical and pharmaceutical industries. Peter Llewellyn previously founded and built the leading industry portal site, InPharm, which was subsequently purchased by John Wiley & Sons to manage alongside their other industry services, PharmaFile and Pharmafocus.
For more information contact:
For more information please contact us via our web site or directly contact Peter Llewellyn, Managing Director, NetworkPharma Ltd, email: peter@networkpharma.com, tel: +44 (0) 1865 865943
